3.3(top 5%)
Impact Factor
3.6(top 5%)
extended IF
156(top 2%)
H-Index
20.6K
authors
24.9K
papers
580.8K
citations
8.3K
citing journals
249.1K
citing authors

Most Cited Articles of Oncotarget

TitleYearCitations
Inflammatory responses and inflammation-associated diseases in organs20181.3K
Combination therapy in combating cancer2017818
Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients2016643
Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β-catenin pathway2015531
The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer2015472
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health2011456
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas2012439
Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer2014415
Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer2016361
EMT, CTCs and CSCs in tumor relapse and drug-resistance2015348
Emerging roles of circRNA_001569 targeting miR-145 in the proliferation and invasion of colorectal cancer2016335
GSK-3 as potential target for therapeutic intervention in cancer2014332
Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival2010332
Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers2011330
An emerging function of circRNA-miRNAs-mRNA axis in human diseases2017325
Recent developments in targeting carbonic anhydrase IX for cancer therapeutics2012325
Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease2015318
The molecular mechanisms of chemoresistance in cancers2017317
Prognostic and predictive value of PDL1 expression in breast cancer2015313
Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway2015310
Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: treating cancer like an infectious disease2015309
Aldehyde dehydrogenase 1A1 in stem cells and cancer2016309
Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a2014306
The regulation of β-catenin activity and function in cancer: therapeutic opportunities2017303
Classification of current anticancer immunotherapies2014301